Public Alert No. 030/2024 – Alert on Confirmed Counterfeit of Avastin in Nigeria
The National Agency for Food and Drugs Administration and Control (NAFDAC) informs the healthcare providers and the public of a report of Confirmed Counterfeit of Avastin in Nigeria. The Marketing Authorization Holder (MAH) Roche reported that an oncologist from a local hospital raised the suspicion for counterfeited material of Avastin Vials 400 mg/16 ml, batch […]
Public Alert No. 029/2024 – Alert on Confirmed Counterfeit of Tecentriq Injection in Nigeria
The National Agency for Food and Drugs Administration and Control (NAFDAC) informs the healthcare providers and the public of a report of Confirmed Counterfeits of Tecentriq injection in Nigeria. The Marketing Authorization Holder (MAH) Roche reported that an oncologist from a local hospital raised the suspicion for counterfeited material of Tecentriq Vials 1200 mg/20 ml, […]
Public Alert No. 028/2024 – Alert on Confirmed Counterfeits of Perjeta in Nigeria
The National Agency for Food and Drugs Administration and Control (NAFDAC) informs the healthcare providers and the public of a report of Confirmed Counterfeits of Perjeta in Nigeria. The Marketing Authorization Holder (MAH) Roche received a complaint from a pharmacist reporting two units of suspected counterfeit Roche products, Perjeta 420 mg/14mL. For the technical investigation, […]
Public Alert No. 027/2024 – Alert on Confirmed Counterfeit of Herceptin in Nigeria
The National Agency for Food and Drugs Administration and Control (NAFDAC) informs the healthcare providers and the public of a report of Confirmed Counterfeit of Herceptin in Nigeria. The Marketing Authorization Holder (MAH) Roche received a complaint from a pharmacist reporting two units of suspected counterfeit Roche product, Herceptin 600 mg/5 ml. For the technical […]
